Genetic testing services providers are in the green after UnitedHealthcare instituted
coverage for Myriad Genetics’ GeneSight test for major depressive disorder.
NeoGenomics (
NEO +5.3%), Invitae (
NVTA +0.9%), Fulgent Genetics (
FLGT+12.8%)
Liquid biopsy services providers are enjoying a bump as well: Biocept (
BIOC+1.9%), Bio-Techne (
TECH +1.6%), Anixa Biosciences (
ANIX +1.9%), OncoCyte (
OCX +0.3%), Guardant Health (
GH +1.9%)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.